Non-alcoholic steatohepatitis registry platform study

Study identifier:D1843R00356

ClinicalTrials.gov identifier:NCT06123858

EudraCT identifier:N/A

CTIS identifier:N/A

Recruiting

Official Title

Non-alcoholic steatohepatitis registry platform study

Medical condition

NASH with fibrosis

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

2500

Study type

Observational

Age

18 Years - 75 Years

Date

Study Start Date: 22 Nov 2023
Estimated Primary Completion Date: 31 Dec 2026
Estimated Study Completion Date: 31 Dec 2026

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Sept 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria